Health Care·Pharmaceuticals·$2.2B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.37 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.37 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management maintained a neutral tone throughout the call. They did not provide specific insights into revenue or future performance.
Management did not provide specific revenue figures during the call.
There was no guidance update offered for future quarters.
Phibro Animal Health reported earnings with an EPS of $0.37 but did not provide revenue figures or future guidance. The stock reacted negatively, declining by 1.16%, likely due to the lack of detailed financial metrics and future outlook from management. Investors may be cautious given the absence of guidance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CENTERPOINT ENERGY I
May 5, 2017